+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, By Type; By Modality; By Application; By End-Use; By Regions; Segment Forecast, 2021 - 2028

  • PDF Icon

    Report

  • 103 Pages
  • April 2021
  • Region: Global
  • Polaris Market Research
  • ID: 5321991
Description Jump to:
The global nuclear medicine market size is expected to reach USD 12.17 billion by 2028 according to this new study. The report “Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, By Type (Diagnostic, Therapeutic, Others); By Modality (Beta-emitters, PET, SPECT, Alpha-emitters, Brachytherapy, Others); By Application; By End-Use; By Regions; Segment Forecast, 2021-2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The different types of nuclear medicine include diagnostic, therapeutic, and others. The diagnostic segment dominated the global radiopharmaceuticals market in 2020. However, nuclear medicine is increasingly being used in therapeutic procedures for the treatment of cancer and thyroid-related conditions. Radioimmunotherapy uses radiation therapy, immunotherapy, and radiotracers for the treatment of certain types of cancer. Brachytherapy uses iridium-192, which is introduced in the body for the destruction of cancer cells.

The market is segmented into Beta-emitters, PET, SPECT, Alpha-emitters, brachytherapy, and others, based on modality. The SPECT (Single-photon emission computed tomography) segment dominated the global Radiopharmaceuticals market in 2020. SPECT scan is a nuclear imaging test that creates 3-D images using a radioactive substance and a special camera.

Some radioisotopes used for SPECT scans include fluorine-18, xenon-133, iodine-123, and thallium-201 among others. SPECT scan examines blood flow to organs and the functioning of internal organs. SPECT scans are mostly used for the diagnosis of heart diseases, brain abnormalities, and bone disorders in the market.

The different applications of nuclear medicine in the market include thyroid, cardiology, bone metastasis, oncology, neurology, gastroenterology, immunology, and others. Nuclear medicine is used in neurology to accurately detect Alzheimer’s diseases, reveal brain abnormalities, and support surgical planning.

The need for high detection accuracy, improved detection speed, and enhanced patient experience has increased the adoption of nuclear medicine. Nuclear medicine enables doctors to diagnose diseases and tumors or recurrence, radiation planning, localization, and track treatment progress.

The hospital segment dominated the global radiopharmaceuticals market in 2020. The growing need for early detection of severe ailments, growing geriatric population, and rising healthcare expenditure in developing countries, such as India, China, and Japan, boost the adoption of nuclear medicine in hospitals.

North America dominated the global radiopharmaceuticals market in 2020 and is expected to maintain its dominance over the forecast period. Rising occurrence of chronic diseases, advanced treatment options, early detection of severe medical conditions, and technological advancements are some factors boosting the adoption of nuclear medicine in the region.

Increasing applications in cancer detection and the presence of well-established healthcare infrastructure further increases the demand for Nuclear Medicine in North America. Asia-Pacific is expected to experience significant growth during the forecast period owing to the increasing geriatric population, rising spending on healthcare, and significant government investments aimed at providing improved healthcare services.

Some of the major market participants include Bracco Imaging S.P.A., Lantheus Medical Imaging, Inc, NTP Radioisotopes Soc, LTD, Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organization, Cardinal Health, Isotopia Molecular Imaging Limited, Bayer AG, The Institute for Radioelements, Curium SAS, Advanced Accelerator Applications, Nordion, Inc, Mallinckrodt, and GE Healthcare.

The publisher has segmented the nuclear medicine market report on the basis of type, modality, application, end-use, and region:


Nuclear Medicine Type Outlook (Revenue, USD Million, 2016-2028)


  • Diagnostic
  • Therapeutic
  • Others

Nuclear Medicine Modality Outlook (Revenue, USD Million, 2016-2028)


  • Beta-emitters
  • PET
  • SPECT
  • Alpha-emitters
  • Brachytherapy
  • Others

Nuclear Medicine Application Outlook (Revenue, USD Million, 2016-2028)


  • Thyroid
  • Cardiology
  • Bone Metastasis
  • Oncology
  • Neurology
  • Gastroenterology
  • Immunology
  • Others

Nuclear Medicine End-User Outlook (Revenue, USD Million, 2016-2028)


  • Hospitals
  • Clinics and Diagnostic Centers
  • Research Institutes
  • Others

Nuclear Medicine Regional Outlook (Revenue, USD Million, 2016-2028)


  • North America
  • U.S
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • RoE
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Colombia
  • RoLATAM
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Israel
  • UAE
  • RoMEA
Frequently Asked Questions about the Nuclear Medicine Market

What is the estimated value of the Nuclear Medicine Market?

The Nuclear Medicine Market was estimated to be valued at $6.19 Billion in 2021.

What is the growth rate of the Nuclear Medicine Market?

The growth rate of the Nuclear Medicine Market is 10.1%, with an estimated value of $12.17 Billion by 2028.

What is the forecasted size of the Nuclear Medicine Market?

The Nuclear Medicine Market is estimated to be worth $12.17 Billion by 2028.

Who are the key companies in the Nuclear Medicine Market?

Key companies in the Nuclear Medicine Market include Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes Soc Ltd, Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organization, Cardinal Health, Isotopia Molecular Imaging Limited, Bayer AG and The Institute for Radioelements.
Report AttributeDetails
No. of Pages103
PublishedApril 2021
Forecast Period2021 - 2028
Estimated Market Value ( USD ) in 2021 $ 6.19 Billion
Forecasted Market Value ( USD ) by 2028 $ 12.17 Billion
Compound Annual Growth Rate10.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Table of Contents

1. Chapter 1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Chapter 2. Executive Summary
2.1. Market Highlights
3. Chapter 3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Chapter 4. Nuclear Medicine Market Insights
4.1. Nuclear Medicine - Industry snapshot
4.2. Nuclear Medicine Market Dynamics
4.2.1. Drivers and Opportunities
4.2.2. Restraints and Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Threats of New Entrants
4.3.3. Bargaining Power of Buyers
4.3.4. Threats of Substitute
4.3.5. Rivalry among existing firms
4.4. Nuclear Medicine Market PESTLE Analysis
4.5. Value Chain Analysis
4.6. Competitive Ranking Analysis, 2020
5. Chapter 5. Nuclear Medicine Market Assessment by Type
5.1. Introduction
5.1.1. Global Nuclear Medicine Market Share, By Type, 2020 & 2028
5.2. Diagnostic
5.2.1. Global Nuclear Medicine Market, by Diagnostic, 2016-2028 (USD Million)
5.2.2. Global Nuclear Medicine Market, by Diagnostic, by Region, 2016-2028 (USD Million)
5.3. Therapeutic
5.3.1. Global Nuclear Medicine Market, by Therapeutic, 2016-2028 (USD Million)
5.3.2. Global Nuclear Medicine Market, by Therapeutic, by Region, 2016-2028 (USD Million)
5.4. Others
5.4.1. Global Nuclear Medicine Market, by Others, 2016-2028 (USD Million)
5.4.2. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
6. Chapter 6. Nuclear Medicine Market Assessment by Modality
6.1. Introduction
6.1.1. Global Nuclear Medicine Market Share, By Modality, 2020 & 2028
6.2. Beta-emitters
6.2.1. Global Nuclear Medicine Market, by Beta-emitters, 2016-2028 (USD Million)
6.2.2. Global Nuclear Medicine Market, by Beta-emitters, by Region, 2016-2028 (USD Million)
6.3. PET
6.3.1. Global Nuclear Medicine Market, by PET, 2016-2028 (USD Million)
6.3.2. Global Nuclear Medicine Market, by PET, by Region, 2016-2028 (USD Million)
6.4. SPECT
6.4.1. Global Nuclear Medicine Market, by SPECT, 2016-2028 (USD Million)
6.4.2. Global Nuclear Medicine Market, by SPECT, by Region, 2016-2028 (USD Million)
6.5. Alpha-emitters
6.5.1. Global Nuclear Medicine Market, by Alpha-emitters, 2016-2028 (USD Million)
6.5.2. Global Nuclear Medicine Market, by Alpha-emitters, by Region, 2016-2028 (USD Million)
6.6. Brachytherapy
6.6.1. Global Nuclear Medicine Market, by Brachytherapy, 2016-2028 (USD Million)
6.6.2. Global Nuclear Medicine Market, by Brachytherapy, by Region, 2016-2028 (USD Million)
6.7. Others
6.7.1. Global Nuclear Medicine Market, by Others, 2016-2028 (USD Million)
6.7.2. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
7. Chapter 7. Nuclear Medicine Market Assessment by Application
7.1. Introduction
7.1.1. Global Nuclear Medicine Market Share, By Application, 2020 & 2028
7.2. Thyroid
7.2.1. Global Nuclear Medicine Market, by Thyroid, 2016-2028 (USD Million)
7.2.2. Global Nuclear Medicine Market, by Thyroid, by Region, 2016-2028 (USD Million)
7.3. Cardiology
7.3.1. Global Nuclear Medicine Market, by Cardiology, 2016-2028 (USD Million)
7.3.2. Global Nuclear Medicine Market, by Cardiology, by Region, 2016-2028 (USD Million)
7.4. Bone Metastasis
7.4.1. Global Nuclear Medicine Market, by Bone Metastasis, 2016-2028 (USD Million)
7.4.2. Global Nuclear Medicine Market, by Bone Metastasis, by Region, 2016-2028 (USD Million)
7.5. Oncology
7.5.1. Global Nuclear Medicine Market, by Oncology, 2016-2028 (USD Million)
7.5.2. Global Nuclear Medicine Market, by Oncology, by Region, 2016-2028 (USD Million)
7.6. Neurology
7.6.1. Global Nuclear Medicine Market, by Neurology, 2016-2028 (USD Million)
7.6.2. Global Nuclear Medicine Market, by Neurology, by Region, 2016-2028 (USD Million)
7.7. Gastroenterology
7.7.1. Global Nuclear Medicine Market, by Gastroenterology, 2016-2028 (USD Million)
7.7.2. Global Nuclear Medicine Market, by Gastroenterology, by Region, 2016-2028 (USD Million)
7.8. Immunology
7.8.1. Global Nuclear Medicine Market, by Immunology, 2016-2028 (USD Million)
7.8.2. Global Nuclear Medicine Market, by Immunology, by Region, 2016-2028 (USD Million)
7.9. Others
7.9.1. Global Nuclear Medicine Market, by Others, 2016-2028 (USD Million)
7.9.2. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
8. Chapter 8. Nuclear Medicine Market Assessment by End-User
8.1. Introduction
8.1.1. Global Nuclear Medicine Market Share, By End-User, 2020 & 2028
8.2. Hospitals
8.2.1. Global Nuclear Medicine Market, by Hospitals, 2016-2028 (USD Million)
8.2.2. Global Nuclear Medicine Market, by Hospitals, by Region, 2016-2028 (USD Million)
8.3. Clinics and Diagnostic Centers
8.3.1. Global Nuclear Medicine Market, by Clinics and Diagnostic Centers, 2016-2028 (USD Million)
8.3.2. Global Nuclear Medicine Market, by Clinics and Diagnostic Centers, by Region, 2016-2028 (USD Million)
8.4. Research Institutes
8.4.1. Global Nuclear Medicine Market, by Research Institutes, 2016-2028 (USD Million)
8.4.2. Global Nuclear Medicine Market, by Research Institutes, by Region, 2016-2028 (USD Million)
8.5. Others
8.5.1. Global Nuclear Medicine Market, by Others, 2016-2028 (USD Million)
8.5.2. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
9. Chapter 9. Nuclear Medicine Market Assessment by Geography
9.1. Introduction
9.1.1. Global Nuclear Medicine Market Share, By Geography, 2020 & 2028
9.2. Nuclear Medicine Market - North America
9.2.1. North America: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
9.2.2. North America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.2.3. North America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.2.4. North America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.2.5. North America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.2.6. Nuclear Medicine Market - U. S.
9.2.6.1. U. S.: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.2.6.2. U. S.: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.2.6.3. U. S.: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.2.6.4. U. S.: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.2.7. Nuclear Medicine Market - Canada
9.2.7.1. Canada: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.2.7.2. Canada: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.2.7.3. Canada: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.2.7.4. Canada: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.3. Nuclear Medicine Market - Europe
9.3.1. Europe: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
9.3.2. Europe: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.3.3. Europe: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.3.4. Europe: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.3.5. Europe: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.3.6. Nuclear Medicine Market - Germany
9.3.6.1. Germany: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.3.6.2. Germany: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.3.6.3. Germany: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.3.6.4. Germany: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.3.7. Nuclear Medicine Market - UK
9.3.7.1. UK: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.3.7.2. UK: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.3.7.3. UK: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.3.7.4. UK: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.3.8. Nuclear Medicine Market - France
9.3.8.1. France: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.3.8.2. France: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.3.8.3. France: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.3.8.4. France: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.3.9. Nuclear Medicine Market - Italy
9.3.9.1. Italy: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.3.9.2. Italy: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.3.9.3. Italy: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.3.9.4. Italy: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.3.10. Nuclear Medicine Market - Spain
9.3.10.1. Spain: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.3.10.2. Spain: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.3.10.3. Spain: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.3.10.4. Spain: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.3.11. Nuclear Medicine Market - Rest of Europe
9.3.11.1. Rest of Europe: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.3.11.2. Rest of Europe: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.3.11.3. Rest of Europe: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.3.11.4. Rest of Europe: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.4. Nuclear Medicine Market - Asia-Pacific
9.4.1. Asia-Pacific: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
9.4.2. Asia-Pacific: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.4.3. Asia-Pacific: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.4.4. Asia-Pacific: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.4.5. Asia-Pacific: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.4.6. Nuclear Medicine Market - China
9.4.6.1. China: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.4.6.2. China: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.4.6.3. China: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.4.6.4. China: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.4.7. Nuclear Medicine Market - India
9.4.7.1. India: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.4.7.2. India: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.4.7.3. India: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.4.7.4. India: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.4.8. Nuclear Medicine Market - Japan
9.4.8.1. Japan: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.4.8.2. Japan: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.4.8.3. Japan: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.4.8.4. Japan: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.4.9. Nuclear Medicine Market - South Korea
9.4.9.1. South Korea: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.4.9.2. South Korea: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.4.9.3. South Korea: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.4.9.4. South Korea: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.4.10. Nuclear Medicine Market - Rest of APAC
9.4.10.1. Rest of APAC: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.4.10.2. Rest of APAC: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.4.10.3. Rest of APAC: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.4.10.4. Rest of APAC: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.5. Nuclear Medicine Market - Latin America
9.5.1. Latin America: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
9.5.2. Latin America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.5.3. Latin America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.5.4. Latin America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.5.5. Latin America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.5.6. Nuclear Medicine Market - Brazil
9.5.6.1. Brazil: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.5.6.2. Brazil: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.5.6.3. Brazil: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.5.6.4. Brazil: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.5.7. Nuclear Medicine Market - Mexico
9.5.7.1. Mexico: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.5.7.2. Mexico: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.5.7.3. Mexico: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.5.7.4. Mexico: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.5.8. Nuclear Medicine Market - Colombia
9.5.8.1. Colombia: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.5.8.2. Colombia: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.5.8.3. Colombia: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.5.8.4. Colombia: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.5.9. Nuclear Medicine Market - Rest of Latin America
9.5.9.1. Rest of Latin America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.5.9.2. Rest of Latin America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.5.9.3. Rest of Latin America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.5.9.4. Rest of Latin America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.6. Nuclear Medicine Market - Middle East and Africa
9.6.1. Middle East & Africa: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
9.6.2. Middle East & Africa: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.6.3. Middle East & Africa: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.6.4. Middle East & Africa: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.6.5. Middle East & Africa: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.6.6. Nuclear Medicine Market - Saudi Arabia
9.6.6.1. Saudi Arabia: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.6.6.2. Saudi Arabia: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.6.6.3. Saudi Arabia: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.6.6.4. Saudi Arabia: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.6.7. Nuclear Medicine Market - South Africa
9.6.7.1. South Africa: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.6.7.2. South Africa: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.6.7.3. South Africa: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.6.7.4. South Africa: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.6.8. Nuclear Medicine Market - Israel
9.6.8.1. Israel: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.6.8.2. Israel: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.6.8.3. Israel: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.6.8.4. Israel: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.6.9. Nuclear Medicine Market - UAE
9.6.9.1. UAE: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.6.9.2. UAE: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.6.9.3. UAE: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.6.9.4. UAE: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
9.6.10. Nuclear Medicine Market - Rest of MEA
9.6.10.1. Rest of MEA: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
9.6.10.2. Rest of MEA: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
9.6.10.3. Rest of MEA: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
9.6.10.4. Rest of MEA: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
10. Chapter 10. Competitive Landscape
10.1. Expansion and Product Launch Analysis
10.1.1. Expansion
10.1.2. Product Launch
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Chapter 11. Company Profiles
11.1. Bracco Imaging S. P. A.
11.1.1. Business Overview
11.1.2. Financial Snapshot
11.1.3. Products and Services Benchmarking
11.1.4. Recent Developments
11.2. Lantheus Medical Imaging, Inc.
11.2.1. Business Overview
11.2.2. Financial Snapshot
11.2.3. Products and Services Benchmarking
11.2.4. Recent Developments
11.3. NTP Radioisotopes Soc, LTD
11.3.1. Business Overview
11.3.2. Financial Snapshot
11.3.3. Products and Services Benchmarking
11.3.4. Recent Developments
11.4. Eckert & Ziegler Group
11.4.1. Business Overview
11.4.2. Financial Snapshot
11.4.3. Products and Services Benchmarking
11.4.4. Recent Developments
11.5. Jubilant Pharma LLC
11.5.1. Business Overview
11.5.2. Financial Snapshot
11.5.3. Products and Services Benchmarking
11.5.4. Recent Developments
11.6. Australian Nuclear Science & Technology Organization
11.6.1. Business Overview
11.6.2. Financial Snapshot
11.6.3. Products and Services Benchmarking
11.6.4. Recent Developments
11.7. Cardinal Health
11.7.1. Business Overview
11.7.2. Financial Snapshot
11.7.3. Products and Services Benchmarking
11.7.4. Recent Developments
11.8. Isotopia Molecular Imaging Limited
11.8.1. Business Overview
11.8.2. Financial Snapshot
11.8.3. Products and Services Benchmarking
11.8.4. Recent Developments
11.9. Bayer AG
11.9.1. Business Overview
11.9.2. Financial Snapshot
11.9.3. Products and Services Benchmarking
11.9.4. Recent Developments
11.10. The Institute for Radioelements
11.10.1. Business Overview
11.10.2. Financial Snapshot
11.10.3. Products and Services Benchmarking
11.10.4. Recent Developments
11.11. Curium SAS
11.11.1. Business Overview
11.11.2. Financial Snapshot
11.11.3. Products and Services Benchmarking
11.11.4. Recent Developments
11.12. Advanced Accelerator Applications
11.12.1. Business Overview
11.12.2. Financial Snapshot
11.12.3. Products and Services Benchmarking
11.12.4. Recent Developments
11.13. Nordion, Inc.
11.13.1. Business Overview
11.13.2. Financial Snapshot
11.13.3. Products and Services Benchmarking
11.13.4. Recent Developments
11.14. Mallinckrodt
11.14.1. Business Overview
11.14.2. Financial Snapshot
11.14.3. Products and Services Benchmarking
11.14.4. Recent Developments
11.15. GE Healthcare
11.15.1. Business Overview
11.15.2. Financial Snapshot
11.15.3. Products and Services Benchmarking
11.15.4. Recent Developments
List of Tables
Table 1. Drivers and Inhibitors for Global Market
Table 2. Restraints Global Market
Table 3. Global Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 4. Global Nuclear Medicine Market, by Diagnostic, by Region, 2016-2028 (USD Million)
Table 5. Global Nuclear Medicine Market, by Therapeutic, by Region, 2016-2028 (USD Million)
Table 6. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
Table 7. Global Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 8. Global Nuclear Medicine Market, by Beta-emitters, by Region, 2016-2028 (USD Million)
Table 9. Global Nuclear Medicine Market, by PET, by Region, 2016-2028 (USD Million)
Table 10. Global Nuclear Medicine Market, by SPECT, by Region, 2016-2028 (USD Million)
Table 11. Global Nuclear Medicine Market, by Alpha-emitters, by Region, 2016-2028 (USD Million)
Table 12. Global Nuclear Medicine Market, by Brachytherapy, by Region, 2016-2028 (USD Million)
Table 13. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
Table 14. Global Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 15. Global Nuclear Medicine Market, by Thyroid, by Region, 2016-2028 (USD Million)
Table 16. Global Nuclear Medicine Market, by Cardiology, by Region, 2016-2028 (USD Million)
Table 17. Global Nuclear Medicine Market, by Bone Metastasis, by Region, 2016-2028 (USD Million)
Table 18. Global Nuclear Medicine Market, by Oncology, by Region, 2016-2028 (USD Million)
Table 19. Global Nuclear Medicine Market, by Neurology, by Region, 2016-2028 (USD Million)
Table 20. Global Nuclear Medicine Market, by Gastroenterology, by Region, 2016-2028 (USD Million)
Table 21. Global Nuclear Medicine Market, by Immunology, by Region, 2016-2028 (USD Million)
Table 22. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
Table 23. Global Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 24. Global Nuclear Medicine Market, by Hospitals, by Region, 2016-2028 (USD Million)
Table 25. Global Nuclear Medicine Market, by Clinics and Diagnostic Centers, by Region, 2016-2028 (USD Million)
Table 26. Global Nuclear Medicine Market, by Research Institutes, by Region, 2016-2028 (USD Million)
Table 27. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
Table 28. Global Nuclear Medicine Market, By Geography, 2016 - 2028 (USD Million)
Table 29. North America: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
Table 30. North America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 31. North America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 32. North America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 33. North America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 34. U.S.: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 35. U.S.: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 36. U.S.: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 37. U.S.: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 38. Canada: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 39. Canada: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 40. Canada: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 41. Canada: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 42. Europe: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
Table 43. Europe: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 44. Europe: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 45. Europe: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 46. Europe: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 47. Germany: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 48. Germany: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 49. Germany: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 50. Germany: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 51. UK: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 52. UK: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 53. UK: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 54. UK: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 55. France: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 56. France: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 57. France: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 58. France: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 59. Italy: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 60. Italy: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 61. Italy: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 62. Italy: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 63. Spain: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 64. Spain: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 65. Spain: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 66. Spain: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 67. Rest of Europe: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 68. Rest of Europe: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 69. Rest of Europe: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 70. Rest of Europe: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 71. Asia-Pacific: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
Table 72. Asia-Pacific: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 73. Asia-Pacific: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 74. Asia-Pacific: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 75. Asia-Pacific: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 76. China: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 77. China: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 78. China: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 79. China: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 80. India: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 81. India: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 82. India: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 83. India: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 84. Japan: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 85. Japan: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 86. Japan: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 87. Japan: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 88. South Korea: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 89. South Korea: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 90. South Korea: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 91. South Korea: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 92. Rest of APAC: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 93. Rest of APAC: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 94. Rest of APAC: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 95. Rest of APAC: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 96. Latin America: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
Table 97. Latin America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 98. Latin America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 99. Latin America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 100. Latin America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 101. Brazil: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 102. Brazil: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 103. Brazil: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 104. Brazil: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 105. Mexico: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 106. Mexico: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 107. Mexico: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 108. Mexico: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 109. Colombia: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 110. Colombia: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 111. Colombia: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 112. Colombia: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 113. Rest of Latin America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 114. Rest of Latin America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 115. Rest of Latin America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 116. Rest of Latin America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 117. Middle East & Africa: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
Table 118. Middle East & Africa: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 119. Middle East & Africa: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 120. Middle East & Africa: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 121. Middle East & Africa: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 122. Saudi Arabia: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 123. Saudi Arabia: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 124. Saudi Arabia: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 125. Saudi Arabia: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 126. South Africa: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 127. South Africa: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 128. South Africa: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 129. South Africa: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 130. Israel: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 131. Israel: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 132. Israel: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 133. Israel: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 134. UAE: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 135. UAE: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 136. UAE: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 137. UAE: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
Table 138. Rest of MEA: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
Table 139. Rest of MEA: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
Table 140. Rest of MEA: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
Table 141. Rest of MEA: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
List of Figures
Figure 1. Market snapshot
Figure 2. Market segmentation & scope
Figure 3. Global Nuclear Medicine market size and growth prospects, 2016 - 2028
Figure 4. Value chain analysis
Figure 5. Nuclear Medicine market dynamics
Figure 6. Key market opportunities - prioritized
Figure 7. Industry analysis - Porter’s
Figure 8. PESTEL analysis
Figure 9. Global Nuclear Medicine market share by Type, 2020 & 2028
Figure 10. Global Nuclear Medicine market share by Modality, 2020 & 2028
Figure 11. Global Nuclear Medicine market share by Application, 2020 & 2028
Figure 12. Global Nuclear Medicine market share by End-User, 2020 & 2028
Figure 13. Global Nuclear Medicine market share by Region, 2020 & 2028
Figure 14. Competitive environment
Figure 15. Strategy framework

Companies Mentioned

  • Bracco Imaging S.P.A.
  • Lantheus Medical Imaging Inc.
  • NTP Radioisotopes Soc Ltd
  • Eckert & Ziegler Group
  • Jubilant Pharma LLC
  • Australian Nuclear Science & Technology Organization
  • Cardinal Health
  • Isotopia Molecular Imaging Limited
  • Bayer AG
  • The Institute for Radioelements
  • Curium SAS
  • Advanced Accelerator Applications
  • Nordion Inc.
  • Mallinckrodt
  • GE Healthcare.

Related Topics

Related Reports

Nuclear Medicine Market- Global Industry Size, Share, Trends, Ciompetition, Opportunity and Forecast, 2017-2027 Segmented By Type, By Application, By End Use, By Region - Product Image

Nuclear Medicine Market- Global Industry Size, Share, Trends, Ciompetition, Opportunity and Forecast, 2017-2027 Segmented By Type, By Application, By End Use, By Region

  • Report
  • 242 Pages
  • Global
From
Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028 - Product Image

Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028

  • Report
  • 342 Pages
  • Global
From
Global Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Cumulative Impact of High Inflation - Forecast 2023-2030 - Product Image

Global Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Cumulative Impact of High Inflation - Forecast 2023-2030

  • Report
  • 224 Pages
  • Global
From
Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, PET Product, and End User - Product Image

Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, PET Product, and End User

  • Report
  • 180 Pages
  • Global
From
Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2027 - Product Image

Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2027

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.